跳至主要内容
临床试验/NCT06993922
NCT06993922招募中不适用

Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management in Patients Undergoing Craniotomy

Ain Shams University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年5月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
1
主要终点
Cumulative postoperative morphine consumption

研究概览

简要总结

This study aims to compare dexmedetomidine as an adjuvant to bupivacaine in scalp block versus bupivacaine alone for postoperative pain management in patients undergoing craniotomy.

详细描述

Scalp block is proposed as a multimodal approach to preventing postoperative pain and hemodynamic responses to previous noxious stimulation during the operation.

The use of adjuvants, such as dexmedetomidine, a highly selective alpha-2 adrenergic receptor agonist, has recently been studied for its analgesic effects. Dexmedetomidine acts additionally to local anesthetics, prolonging their duration of action.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age from 18 to 65 years.
  • •Both sexes.
  • •American Society of Anesthesiologists (ASA) physical status I or II.
  • •Undergoing supratentorial elective planned craniotomies.

排除标准

  • •Patients refusal.
  • •History of known allergy to the used local anesthetic or dexmedetomidine.
  • •Bleeding disorders.
  • •Evidence of local infection at the site of injection.
  • •Emergency craniotomy.
  • •Psychotic disorder.
  • •Patients who will not be extubated in the operating room after surgery.

研究组 & 干预措施

Group SB

Active Comparator

Patients will receive a scalp block with bupivacaine alone.

干预措施: Scalp block (Other)

Group SD

Experimental

Patients will receive a scalp block with dexmedetomidine as an adjuvant to bupivacaine.

干预措施: Scalp block + Dexmedetomidine (Other)

结局指标

主要结局

Cumulative postoperative morphine consumption

时间窗: 24 hours postoperatively

If the Visual Analogue Scale (VAS) score is ≥3, rescue analgesia will be administered; intravenous morphine will be given at a dose of 0.05 mg/kg

次要结局

  • Time for 1st rescue analgesia(24 hours postoperatively)
  • Incidence of complications(24 hours postoperatively)
  • Heart rate(24 hours postoperatively)
  • Mean arterial pressure(24 hours postoperatively)
  • Degree of pain(24 hours postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Omar Ahmed Zakaria Khiralla

Resident of Anaesthesia, Intensive Care Unit and Pain, Faculty of Medicine, Ain shams University, Cairo, Egypt.

Ain Shams University

研究点 (1)

Loading locations...

相似试验